Recently, the Novartis Group, a global pharmaceutical giant toward the goal of a major step forward. 2010 global stock market opened the first day, this world number seven major pharmaceutical companies announced a further investment of about $ 39.3 billion, China wrist blood pressure monitor from Nestle and the hands of minority shareholders, the acquisition of the world's largest wholly-owned ophthalmic pharmaceutical and medical device companies ---- headquartered in Switzerland, listed in the U.S. company Alcon. Novartis chairman Daniel Vasella said in a statement: "The acquisition of eye care industry in the world's leading company Alcon, for us it is a China forehead thermometer great opportunity. On the whole, I think this is a very in line with company strategy transaction, and the business prospects are very optimistic. "
...